Spirulina Gastric Emptying Breath Test (GEBT)

About Cairn Diagnostics

Cairn Diagnostics is a U.S.-based diagnostics company that has commercialized the first FDA-approved at-home breath test for gastroparesis, the Gastric Emptying Breath Test (GEBT). This test provides a non-radioactive, convenient alternative to the traditional scintigraphy test, which requires a hospital visit and exposure to trace radiation. The company targets the over 5 million patients suffering from gastroparesis, with a particular focus on diabetics, and leverages telehealth for test administration. Cairn operates as a commercial-stage, private company offering a direct diagnostic solution.

Therapeutic Areas